Transaction in Own Shares

Summary by AI BETAClose X

Reckitt Benckiser Group plc has purchased 59,420 of its ordinary shares on November 26, 2025, at an average price of 5,889.07 pence per share, with the highest price paid being 5,918.00 pence and the lowest 5,808.00 pence. These repurchased shares will be held in treasury, bringing the total number of shares held in treasury to 58,823,901 and the total number of ordinary shares in issue, excluding treasury shares, to 673,265,438. This results in a total of 673,265,438 voting rights, which shareholders can use as a denominator for notification purposes under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Reckitt Benckiser Group PLC
27 November 2025
 

Transaction in own shares

 

Reckitt Benckiser Group plc (the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each ("shares") from BNP PARIBAS SA in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 25 September 2025, as announced on 26 September 2025. The repurchased shares will be held in treasury.

 Ordinary Shares

Date of purchase:

26 November 2025

Aggregate number of ordinary shares purchased:

59,420

Highest price paid per share (pence):

5,918.00

Lowest price paid per share (pence):

5,808.00

Volume weighted average price paid per share (pence):

5,889.07

 

Following the above transaction, the Company will hold 58,823,901 of its ordinary shares in treasury and have 673,265,438 ordinary shares in issue (excluding treasury shares).

Therefore, the total number of voting rights in the Company will be 673,265,438 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a full breakdown of the individual trades made by the Broker on behalf of the Company is detailed below: 

 

http://www.rns-pdf.londonstockexchange.com/rns/1581J_1-2025-11-26.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings